Literature DB >> 32425432

Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.

Tzung-Dau Wang1.   

Abstract

Entities:  

Year:  2020        PMID： 32425432      PMCID： PMC7220966          DOI： 10.6515/ACS.202005_36(3).20200430A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  27 in total

1.  Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.

Authors:  Masato Furuhashi; Norihito Moniwa; Tomohiro Mita; Takahiro Fuseya; Shutaro Ishimura; Kohei Ohno; Satoru Shibata; Marenao Tanaka; Yuki Watanabe; Hiroshi Akasaka; Hirofumi Ohnishi; Hideaki Yoshida; Hideki Takizawa; Shigeyuki Saitoh; Nobuyuki Ura; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

2.  Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats.

Authors:  Wei-Ting Chen; Chang-Bie Shie; Chen-Chia Yang; Tsung-Ming Lee
Journal:  Acta Cardiol Sin       Date:  2019-03       Impact factor: 2.672

3.  Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015.

Authors:  Yi-Heng Li; Yu-Wei Chiu; Jun-Jack Cheng; I-Chang Hsieh; Ping-Han Lo; Meng-Huan Lei; Kwo-Chang Ueng; Fu-Tien Chiang; Shih-Hsien Sung; Jen-Yuan Kuo; Ching-Pei Chen; Wen-Ter Lai; Wen-Lieng Lee; Jyh-Hong Chen
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

4.  Targeted Next Generation Sequencing for Genetic Mutations of Dilated Cardiomyopathy.

Authors:  Jih-Kai Yeh; Wei-Hsiu Liu; Chao-Yung Wang; Jang-Jih Lu; Chien-Hsiun Chen; Yah-Huei Wu-Chou; Pi-Yueh Chang; Shih-Cheng Chang; Chia-Hung Yang; Ming-Lung Tsai; Ming-Yun Ho; I-Chang Hsieh; Ming-Shien Wen
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

5.  The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Mevlüt Serdar Kuyumcu; Aliye Kuyumcu; Çağrı Yayla; Mustafa Bilal Özbay; Sefa Ünal; Burak Açar; Cemil Nural; Almila Şenat; Gülhan Samur
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

6.  Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.

Authors:  Brian P Halliday; Rebecca Wassall; Amrit S Lota; Zohya Khalique; John Gregson; Simon Newsome; Robert Jackson; Tsveta Rahneva; Rick Wage; Gillian Smith; Lucia Venneri; Upasana Tayal; Dominique Auger; William Midwinter; Nicola Whiffin; Ronak Rajani; Jason N Dungu; Antonis Pantazis; Stuart A Cook; James S Ware; A John Baksi; Dudley J Pennell; Stuart D Rosen; Martin R Cowie; John G F Cleland; Sanjay K Prasad
Journal:  Lancet       Date:  2018-11-11       Impact factor: 79.321

7.  Early Phase II Comprehensive Cardiac Rehabilitation after Acute Myocardial Infarction.

Authors:  Yun-Jeng Tsai; Wei-Chun Huang; Tzu-Pin Weng; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-07       Impact factor: 2.672

8.  Protective Roles and Mechanisms of Taurine on Myocardial Hypoxia/Reoxygenation-Induced Apoptosis.

Authors:  Xiaohong Yang; Jingjing Fu; Huifang Wan; Zhuoqi Liu; Lehan Yu; Bo Yu; Fusheng Wan
Journal:  Acta Cardiol Sin       Date:  2019-07       Impact factor: 2.672

Review 9.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

Authors:  Mahmoud Gheblawi; Kaiming Wang; Anissa Viveiros; Quynh Nguyen; Jiu-Chang Zhong; Anthony J Turner; Mohan K Raizada; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2020-04-08       Impact factor: 17.367

10.  SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.

Authors:  G Y Oudit; Z Kassiri; C Jiang; P P Liu; S M Poutanen; J M Penninger; J Butany
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.